Careers
Contact Us
Who We Are
Who We Are
Our History
Mission & Values
Our Team
Leadership
Board of Directors
Careers
ARCUS Genome Editing
ARCUS Genome Editing
Scientific Publications
Pipeline
PBGENE-HBV
Investors
Events & Presentations
Press Releases
Corporate Deck
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Sustainability
Investor FAQs
Partnering
Chris Robinson
A Gene Editing Approach to Eliminate Hepatitis B Virus Using ARCUS Meganucleases
by Chris Robinson
Integration of a CD19 CAR Into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
by Chris Robinson
Off the Shelf T Cell Therapies for Hematologic Malignancies
by Chris Robinson
Initial Findings of the Phase 1 Trial of PBCAR0191, a CD19 Targeted Allogeneic CAR T Cell Therapy
by Chris Robinson
1
2